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Abstract
Secretion of outer membrane vesicles (OMV) is an intriguing phenomenon of Gram-negative bacteria and has been
suggested to play a role as virulence factors. The respiratory pathogens Moraxella catarrhalis reside in tonsils adjacent to B
cells, and we have previously shown that M. catarrhalis induce a T cell independent B cell response by the immunoglobulin
(Ig) D-binding superantigen MID. Here we demonstrate that Moraxella are endocytosed and killed by human tonsillar B cells,
whereas OMV have the potential to interact and activate B cells leading to bacterial rescue. The B cell response induced by
OMV begins with IgD B cell receptor (BCR) clustering and Ca
2+ mobilization followed by BCR internalization. In addition to
IgD BCR, TLR9 and TLR2 were found to colocalize in lipid raft motifs after exposure to OMV. Two components of the OMV,
i.e., MID and unmethylated CpG-DNA motifs, were found to be critical for B cell activation. OMV containing MID bound to
and activated tonsillar CD19
+ IgD
+ lymphocytes resulting in IL-6 and IgM production in addition to increased surface marker
density (HLA-DR, CD45, CD64, and CD86), whereas MID-deficient OMV failed to induce B cell activation. DNA associated with
OMV induced full B cell activation by signaling through TLR9. Importantly, this concept was verified in vivo, as OMV
equipped with MID and DNA were found in a 9-year old patient suffering from Moraxella sinusitis. In conclusion, Moraxella
avoid direct interaction with host B cells by redirecting the adaptive humoral immune response using its superantigen-
bearing OMV as decoys.
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Introduction
Moraxella catarrhalis is one of the major respiratory pathogens in
humans causing acute otitis media in children, sinusitis and
laryngitis in adults as well as exacerbations in patients diagnosed
with chronic obstructive pulmonary disease (COPD) [1,2]. The M.
catarrhalis carriage varies during life from very high in young
children to low in healthy adults. Recent findings that M. catarrhalis
could hide intracellularly and the fact that biofilm forming bacteria
like Moraxella are easily overlooked in swab samples suggest that
the overall colonization of M. catarrhalis could be underestimated
[3–5]. A study of pharyngeal lymphoid tissue using fluorescent in
situ hybridization (FISH) has shown that 91% of the adenoids and
85% of the palatine tonsils harbour M. catarrhalis [6]. It was also
demonstrated that M. catarrhalis colocalizes with B cells in the outer
mantel zone of the lymphoid follicles. Thus, these observations in
human tonsils explain where the non-invasive pathogen M.
catarrhalis may interact with B cells.
M. catarrhalis interferes with the immune system in several ways
[7]. One of its most intriguing interactions is the IgD-binding
capacity (for a review see [8]). The outer membrane protein and
superantigen Moraxella immunoglobulin (Ig) D binding protein
(MID) is a trimeric autotransporter [9] and the IgD-binding
domain is located within amino acids 962-1200 (MID962-1200)
[10]. MID binds to amino acids 198–224 in the CH1 region on
human IgD [11] and this non-immune cross-linking explains the
mitogenic effect of M. catarrhalis on IgD
+ human B cells [12].
Cross-linking of the BCR leads to receptor-mediated endocytosis
of whole bacteria and a lower threshold for pathogen recognition
receptor (PRR) signalling in the B cell [13]. Toll-like receptor
(TLR) 9 is the most important PRR in M. catarrhalis-induced B cell
activation, but TLR1, TLR2 and TLR6 also contribute to the
activation. B cell activation by M. catarrhalis leads to a polyclonal
IgM production, suggesting a delayed production of protective
antibodies [12,14].
All Gram-negative bacteria naturally release outer membrane
vesicles (OMV) during both planktonic growth and in surface-
attached biofilm communities [15]. These spherical bilayered
OMV are liberated from the outer membrane and range in size
from 50–250 nm in diameter. OMV produced by pathogenic
bacteria contain adhesins, invasins and immunomodulatory
compounds such as lipopolysaccharide (LPS) (for a review see
PLoS Pathogens | www.plospathogens.org 1 January 2010 | Volume 6 | Issue 1 | e1000724[16,17]). Production of OMV represents a distinct secretion
mechanism that allows bacteria to release and disseminate a large,
complex group of proteins and lipids into the extracellular milieu.
Several studies have demonstrated that OMV play a role as
protective transport vesicles, delivering toxins, enzymes and DNA
to eukaryotic cells as well as being key factors in natural
competence [18–22]. OMV can also improve bacterial survival
in the host by directly mediate bacterial binding and invasion,
causing cytotoxicity, and modulating the host immune response
[23,24]. By acting as decoys to the immune system, OMV may
enable bacteria to evade immune detection during colonization,
binding and removing cell-targeted bactericidal factors. We have
previously shown that OMV from M. catarrhalis contribute to an
increased survival of Haemophilus influenzae in human serum by
binding and neutralizing C3 in vitro [25]. Thus, based upon several
lines of evidence it is clear that OMV produced by colonizing
pathogens have a complex and as yet unexplored impact on the
immune response. In this study, we examined the capacity of
OMV to interact with human B cells isolated from pharyngeal
lymphoid tissues, where M. catarrhalis can reside [6], and in detail
studied the virulence factors and mechanisms involved in this
process.
Results
M. catarrhalis that are endocytosed by human tonsillar B
lymphocytes do not survive intracellularly
M. catarrhalis can be found adjacent to B cells in tonsils [6] and
we have recently shown that this pathogen is internalized by
tonsillar B cells [13]. Intracellular survival of bacteria in B cells
would thus be a potential escape mechanism in the host. To test
this hypothesis, we isolated B cells from human tonsils by negative
selection. To ensure the purity of the B cell preparation, all
isolated lymphocytes were screened for CD3, CD19, and IgD
expression by flow cytometry (Fig. 1A–D). Tonsillar B cells were
incubated with M. catarrhalis BBH18 (Table 1) or an isogenic
mutant deficient in the IgD-binding protein MID (BBH18 Dmid)
for 1 h. Extracellular bacteria were killed by gentamicin in a
conventional survival assay and the intracellular fate was assessed
at different time points. Interestingly, intracellularly residing
bacteria were rapidly killed by B lymphocytes suggesting that this
cell type would not be a reservoir for Moraxella (Fig. 1E). In
contrast, non-IgD binding bacteria as demonstrated with the
mutant M. catarrhalis BBH18 Dmid were not taken up by B cells as
compared to the MID-expressing wild type. The MID-expressing
wild type Moraxella bound soluble IgD, whereas the MID-deficient
mutant did not as revealed by flow cytometry analysis (Fig. 1E;
insert). Finally, B cell viability was not affected by the presence of
M. catarrhalis at the different time points evaluated (Fig. 1F).
We have previously shown that MID binds both secreted and
membrane bound IgD [11,26]. The human serum concentration
of IgD is very low [27], i.e., IgD represents less than 0.25% of the
total Ig concentration in serum. To determine whether IgD could
block the IgD-dependent bacterial interaction with B cells, FITC-
labelled M. catarrhalis was incubated with tonsillar B cells in the
presence of purified serum IgD. At the highest physiological IgD
concentration tested (50 mg/ml), no decrease in bacterial binding
to B cells was detected as compared to the control without IgD
(Fig. 1G). However, when the IgD concentration was increased up
to three-fold (150 mg/ml), a 40% reduction of binding to B cells
was found. To exclude that IgD-binding to FITC-Moraxella was
not quenched by the FITC conjugation, the capacity of FITC-
labelled M. catarrhalis to bind purified IgD was also tested. A
preserved bacterial IgD-binding was found when IgD binding was
analysed with an RPE-conjugated rabbit anti-human IgD pAb
(Fig. 1G; inserts). Our findings raised the question why Moraxella is
equipped with the superantigen MID, since expression of MID
would be potentially harmful for bacterial survival when
endocytosed by B cells.
Moraxella OMV bind to B lymphocytes by a MID-
dependent mechanism
OMV secreted by M. catarrhalis would theoretically also contain
MID as vesicles basically comprise outer membrane components,
i.e., LPS, phospholipids and outer membrane proteins. The
potential of OMV to carry and long-distance deliver diverse
virulence factors prompted us to hypothesize that Moraxella OMV
can activate human B cells as has been proven with whole bacteria
[13,14]. The initial step in B cell activation requires M. catarrhalis
OMV binding to B cells. To study the capacity of OMV to
interact with tonsillar B cells, OMV isolated from overnight
cultures of different M. catarrhalis strains were labelled with FITC
and incubated with purified B cells for 1 h. After several washing
steps, the binding of FITC-conjugated OMV was analyzed by flow
cytometry (Fig. 2A). The binding of OMV to B cells was
concentration dependent and saturated above 10 mg/ml (Fig. 2B).
In agreement with our previous observations based on analysis of
whole bacteria [13], the interaction between B cells and OMV
involved the presence of the IgD-binding outer membrane protein
MID as OMV isolated from MID-deficient mutants (OMV Dmid),
barely bound to purified B cells at the different concentrations
tested (Fig. 2A and B). Moreover, OMV isolated from mutants
deficient in ubiquitous surface protein (Usp) A1 and A2, two other
important multifunctional Moraxella surface virulence factors
[28,29], were also shown to bind to tonsillar B cells at the same
level as the wild type MID-containing OMV.
The interaction between OMV and B cells was further analyzed
by transmission electron microscopy (TEM) after co-culturing B
cells with live M. catarrhalis for 1 h allowing them to produce
natural OMV. The M. catarrhalis OMV clearly bound to the B cell
Author Summary
Outer membrane vesicles secreted by pathogenic bacteria
are recognized as a long-distance delivery system which
transports diverse virulence factors, and allows pathogens
to interact with the host, and hence the possibility to
modify the immune response without close contact. Our
study shows that Moraxella catarrhalis outer membrane
vesicles that also exist in patients can activate human B
cells isolated from pharyngeal lymphoid tissue. These
findings have significant implications for understanding
Moraxella pathogenesis since palatine tonsils are a
potential tissue reservoir. Vesicles secreted by Moraxella
bind to tonsillar B cells through the superantigen
Moraxella IgD-binding protein designated MID. The
interaction between MID and the B cell receptor induces
Ca
2+ mobilization and receptor clustering in lipid raft
motifs followed by internalization of vesicles. Mainly Toll-
like receptor 9, a pathogen recognition receptor of the
innate immune system, participates in the signaling
induced by vesicles through sensing of DNA associated
with vesicles. The vesicle-dependent B cell activation
induces up-regulation of surface activation markers in
addition to IL-6 and IgM secretion. Vesicle secretion
provides Moraxella with a sophisticated mechanism to
modify the host immune response, avoiding contact
between bacteria and the host.
M. catarrhalis OMV Activate B Cells
PLoS Pathogens | www.plospathogens.org 2 January 2010 | Volume 6 | Issue 1 | e1000724Figure 1. Internalized MID-expressing M. catarrhalis do not survive in tonsillar B cells. (A) A representative dot plot displaying forward and
side scatters of the purified tonsillar B cells used for live-cell gating. Each preparation of purified tonsillar B lymphocytes were analysed as routine
control by flow cytometry for IgD (B), CD19 (C), and CD3 (D) expression. White profiles correspond to the isotype control Abs used as negative
controls. Representative flow cytometry plots are shown. (E) M. catarrhalis wild type (BBH18 wt) or an isogenic MID-deficient mutant (BBH18 Dmid)
were incubated with purified tonsillar B lymphocytes for 1 h. Thereafter, B cells were washed and treated with gentamicin to kill extracellular bacteria
followed by thorough washes. At the indicated times, infected cells were lysed mechanically and plated on agar plates. Colony forming units (cfu)
were counted after incubation for 24 h at 37uC. The mean values of three separate experiments with different donors are demonstrated. Error bars
indicate SEM. Insert shows IgD binding to M. catarrhalis BBH18 wt and the MID-deficient mutant BBH18 Dmid. Bacteria were grown on solid medium
overnight. After incubation with a human IgD standard serum followed by a FITC-conjugated anti-human IgD pAb and several washings, bacteria
were analyzed by flow cytometry. (F) The viability of B cells infected with M. catarrhalis BBH18 wt and BBH18 Dmid was assessed at the indicated
times by trypan blue exclusion staining. The mean values of three independent experiments are demonstrated. Error bars indicate SEM. (G) The
capacity of purified human IgD to block M. catarrhalis binding to B cells was analyzed by flow cytometry. FITC-labelled M. catarrhalis wild type were
treated with increased concentrations of purified human IgD, washed and incubated with human B cells for 30 min at 37uC. After several washes,
bacterial binding to B cells were analyzed by flow cytometry. The mean values of three independent experiments are demonstrated. Error bars
indicate SEM. Insert shows IgD-binding to FITC-labelled M. catarrhalis. Bacteria were incubated with a human IgG standard (50 mg/ml) (left panel) or
purified IgD (50 mg/ml) (right panel). After several washes, Moraxella were incubated with an RPE-conjugated anti-human IgD mAb and analyzed by
flow cytometry.
doi:10.1371/journal.ppat.1000724.g001
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to our flow cytometry experiments, MID deficient OMV did not
significantly bind to B cells as revealed by TEM (data not shown).
The interplay between MID-containing OMV and the IgD B cell
receptor (BCR) on host cells was also observed using gold-labelled
antibodies directed against either IgD (large granules; white
arrows) or the MID protein (small granules; black arrows) (Fig. 2E
and F). We found that on the average 83% of the large gold
granules (representing the IgD BCR) and 79% of the small gold
particles (MID) were associated with plasma membranes and
OMV, respectively. In addition, 36% of all gold particles were
found colocalized at the interface between OMV and the plasma
membrane.
To confirm the presence or absence of MID in the different
OMV preparations, OMV were analyzed by SDS-PAGE and
Western blot using rabbit pAbs directed against the KTRASS
repeat within the IgD binding region of MID [10] (Fig. 2G and H).
Thus, OMV originating from the MID-expressing M. catarrhalis
BBH18 wild type (wt) and UspA-deficient mutants contained the
outer membrane protein MID, whereas OMV obtained from the
MID-deficient mutants M. catarrhalis were consequently deficient
in MID.
OMV induce Ca
2+ mobilization and clustering of B cell
receptors by lipid rafts
BCR cross-linking results in the recruitment and activation of
several signaling components and triggers the generation of second
messengers, i.e., inositol 1,4,5-triphosphate (InsP3) and diacylgly-
cerol. InsP3 induces calcium release from internal stores into the
cytoplasm and promotes calcium entrance through the plasma
membrane which ultimately increases the intracellular calcium
concentration and results in activation of gene expression. To
determine whether the binding of OMV mobilizes Ca
2+ ions in
human tonsillar B lymphocytes, we measured Ca
2+ mobilization in
Fura-2 loaded cells. Ionomycin was used as a positive control, and
as shown in Figure 3A, OMV at 10 mg/ml induced a rapid, strong
and transient elevation of [Ca
2+]i in B cells. MID-deficient OMV
also induced a Ca
2+ mobilization although significantly lower as
compared to the wild type OMV.
Ligation of the BCR with antigen induces lipid raft coalescence,
a process that allows concentration of key signaling molecules and
promotes contact between them to ensure efficient and sustained
signal transduction [30–32]. In initial experiments our TEM
analysis revealed a clustering of the IgD BCR at the B cell surface
when cells were exposed to MID-containing OMV (Fig. 2F; white
arrows). Biochemical evidence of lipid rafts in B cells was obtained
by the isolation of Triton-insoluble material from purified B cells
before and after exposure to OMV or formaldehyde-fixed M.
catarrhalis wild type that were used as a positive control. The
Triton-insoluble material was then fractionated on a discontinuous
sucrose gradient and aliquots were screened by Western blots with
specific antibodies (Fig. 3B). Flotillin and caveolin were used as
markers for raft fractions [33]. Importantly, IgD, TLR2 and
TLR9 were found in the raft fractions of cells stimulated with
either bacteria or OMV. To confirm the compartmentalization of
receptors into lipid rafts, we treated B cells with filipin, which
intercalates into lipid motifs and hereby disrupts lipid raft
structures [34]. The partitioning of TLR2, TLR9 and IgD
induced by OMV was prevented in B cells treated with filipin and
thus the lipid raft fractions did not include these molecules
(Fig. 3B).
Fluorescence and confocal microscopy also revealed that lipid
raft domains coalesce into large patches on the B cell surface after
OMV stimulation. Unstimulated B cells exhibited a weak
generalized membrane flotillin and TLR2 staining, which we
assume indicated the presence of small lipid rafts. BCR stimulation
via MID-containing OMV (OMV wt) caused a clear polarization
of lipid rafts as was observed by the punctuate staining over a few
regions of each cell (Fig. 3C). The percentage of B cells stimulated
with OMV wt showing polarization of lipid rafts was 89.762%
(mean value6SD, n=7 different experiments) compared to
1.161% of B cells stimulated with MID-deficient OMV.
Colocalization between Flotillin, TLR2 or TLR9 and IgD BCR
induced by OMV was also confirmed by double staining of
stimulated B cells followed by confocal analysis (Fig. 3D).
Interestingly, IgD BCR and TLR9 colocalized with the early
endosomal marker Rab5 on B cell endosomal compartments after
OMV stimulation for 30 min. Thus, by using both TEM (Fig. 2F)
and biochemical data in addition to confocal microscopy we have
shown that OMV binding initiates IgD BCR clustering.
OMV are taken up by human B cells through a
BCR-mediated mechanism
Antigen-induced clustering of the BCR is normally followed by
BCR internalization and movement to endosomal compartments.
To explore the expression of IgD after binding of OMV, B cells
were incubated in the presence of different OMV concentrations.
Cells were harvested after 24 h and analyzed for changes in IgD
and IgM expression using flow cytometry analysis. The surface
expressed IgD was strongly down regulated in the presence of
OMV (Fig. 4A). In contrast, IgM density was not affected by
OMV. The kinetics of the OMV-induced IgD down-regulation
was further analyzed comparing IgD expression on B cells
incubated with either wild type OMV or MID-deficient OMV
(Fig. 4B). A significant decrease in IgD density was detected as
early as after one hour of incubation with MID-containing OMV
Table 1. Moraxella catarrhalis strains used in the present study.
Strain Phenotype Reference
BBH18 wt Clinical isolate, wild type [42]
BBH18 Dmid MID-deficient [67,68]
BBH18 DuspA1 UspA1-deficient [60]
BBH18 DuspA2 UspA2-deficient [60]
BBH18 DuspA1/A2 UspA1/A2-deficient [60]
BBH18 Dmid/uspA1/2 MID and UspA1/A2-deficient [60,67]
KR971 Clinical isolate from a 9 year-old child with sinusitis this study
doi:10.1371/journal.ppat.1000724.t001
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PLoS Pathogens | www.plospathogens.org 4 January 2010 | Volume 6 | Issue 1 | e1000724Figure 2. M. catarrhalis OMV bind to tonsillar lymphocytes through an interaction via MID and the IgD B cell receptor. (A) A typical
flow cytometry experiment with OMV and B cells. Control B lymphocytes (shaded) and cells incubated with FITC-labelled OMV wild type (OMV-wt) or
MID-deficient OMV (OMV-Dmid). OMV were used at 10 mg/ml and incubated with B cells for 1 h at 37uC. (B) Concentration-dependent binding of
OMV to B cells. Increased concentrations of FITC-labeled OMV were incubated with B cells for 1 h followed by flow cytometry analyses. Data are
presented as mean6SEM of 3 experiments. (C, D) B cells and OMV interactions analyzed in TEM showed binding of several OMV to the B cell surface.
(E, F) IgD molecules were clustered upon OMV binding: gold-labelled antibodies demonstrated formation of a tight cluster of IgD (large granules;
white arrows) and MID (small granules; black arrows). The bars represent 100 nm in length. The expression of MID in OMV isolated from different M.
catarrhalis isogenic mutants was analyzed by SDS-PAGE (G) and Western blot (H) using MID specific rabbit pAbs. Molecular weight markers in
kilodalton are indicated to the left.
doi:10.1371/journal.ppat.1000724.g002
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PLoS Pathogens | www.plospathogens.org 5 January 2010 | Volume 6 | Issue 1 | e1000724Figure 3. Ca
2+ mobilization and B cell receptor clustering are induced by OMV. (A) Mobilization of [Ca
2+]i in human tonsillar B cells induced
by Moraxella OMV. Purified Fura-2 loaded B cells were stimulated with wild-type OMV (10 mg/ml), MID-deficient OMV (10 mg/ml) or ionomycin
(100 nM). Ca
2+ mobilization was analyzed as described in Materials and Methods. Each experiment was repeated with at least three different donors
with comparable results. (B) Aliquots of Triton-insoluble lysates of B cells obtained before (Control) and after stimulation with formaldehyde-fixed M.
catarrhalis wild type (Bacteria), OMV or treated with filipin prior to stimulation with OMV (Filipin + OMV) were fractionated on discontinuous sucrose
gradients and were immunoblotted with anti-flotillin, anti-caveolin, anti-TLR2, anti-IgD or anti-TLR9 mAbs. (C) Visualization of receptor clustering in
lipid rafts. B cells unstimulated (Control), wild type OMV (OMV wt) or MID-deficient OMV (OMV Dmid) stimulated for 30 min were fixed and stained
with anti-flotillin (top) or anti-TLR2 (bottom). Alexa Fluor 594 goat anti-mouse IgG pAb were used as a secondary layer. (D) Colocalization of flotillin,
TLR2, Rab5 and TLR9 with IgD (BCR) confirmed by confocal microscopy. Purified B cells were incubated with OMV for 30 min, fixed and stained with
FITC-conjugated or RPE-conjugated mAbs against IgD (BCR) and FITC-conjugated anti-TLR9 mAb, anti-flotillin mAb or anti-TLR2 mAb using Alexa
Fluor 594-conjugated secondary pAb. For the triple staining, stimulated B cells were incubated with rabbit anti-IgD pAb (BCR) and mouse anti-Rab5
mAb (Rab5). After several washes, B cells were incubated with Alexa Fluor 633 goat anti-mouse IgG and Alexa Fluor 546 goat anti-rabbit IgG
secondary mAb followed by incubation with FITC-conjugated anti-TLR9 mAb (TLR9). The lymphocytes shown are representatives of more than 90%
of the cells imaged in 3 separate experiments with different donors.
doi:10.1371/journal.ppat.1000724.g003
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PLoS Pathogens | www.plospathogens.org 6 January 2010 | Volume 6 | Issue 1 | e1000724Figure 4. OMV induce a down-regulation of surface expressed IgD in a dose dependent manner and are internalised by tonsilar B
cells. Changes in surface expression of IgD and IgM after OMV binding to B cells were analyzed by flow cytometry. (A) Purified tonsil B cells were
incubated with different concentrations of OMV ranging from 150 ng/ml to 10 mg/ml and monitored for IgD and IgM expression after 24 h at 37uC.
Insert shows a representative flow cytometry profile of IgD-labelled B cells that were left unstimulated (shaded) or stimulated with OMV (white). (B)
The kinetics of IgD internalization was examined after incubation with 10 mg of either OMV wild type (OMV-wt) or MID-deficient OMV (OMV-Dmid).
Data are shown as arbitrary units comparing Ig densities at different time-points with expression at time 0 h set to 100%. Error bars indicate SEM from
four and three different donors in panels A and B, respectively. Insert shows a representative flow cytometry profile of IgD-labelled B cells that were
unstimulated (shaded) or stimulated with OMV wt (white). (C) The IgD internalization after OMV stimulation was examined by flow cytometry.
Unstimulated (control) B cells or B cells stimulated with 10 mg/ml of OMV wild type (OMV wt) or MID-deficient OMV (OMV Dmid) were fixed and
incubated with FITC-conjugated anti-CD19 mAb and rabbit anti-IgD pAb to block the surface expressed BCR. After several washes, B cells were
permeabilized and incubated with RPE-conjugated anti-IgD mAb and analyzed by flow cytometry. The data shown are representative of those from
three independent experiments. (D) Representative flow cytometry experiment of OMV entry into B cells. Control B cells (shaded) and cells incubated
with FITC–labeled OMV before (OMV-FITC) and after quenching with trypan blue (OMV-FITC + trypan blue). (E, F) B cells and OMV interactions
analyzed in TEM showed internalisation of MID containing OMV. The endosome with two OMV is magnified in (F) and gold-labelled antibodies
against IgD (large granules; white arrows) and MID (small granules; black arrows) are indicated. The scale in (E) and (F) represents 1 mm and 100 nm in
length, respectively.
doi:10.1371/journal.ppat.1000724.g004
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expression was not affected in the presence of MID-deficient
OMV. To relatively quantify the internalization of the IgD BCR
after OMV stimulation, intracellular IgD was analysed in tonsillar
B cells stimulated for 30 min with either MID-containing or MID-
deficient OMV (Fig. 4C). The number of CD19
+ lymphocytes
with intracellular IgD increased 28.169% (mean value6SD,
n=4) as compared to unstimulated B cells or cells stimulated with
MID-deficient OMV.
To further study the entry of OMV into B cells, we used a
fluorescence quenching method [35]. FITC-labeled OMV were
incubated with B cells for 1 h, followed by extensive washing steps
and flow cytometry analysis. The mean fluorescence of cells with
bound OMV (extra- and intracellular) was compared with
intracellular OMV after addition of trypan blue, which quenches
the extracellular FITC signal (i.e., only intracellular OMV would
then be fluorescent). As shown in Figure 4D, after 1 h incubation
with FITC-conjugated OMV 76.662.3% of the B cells had
internalized the OMV-FITC. Notably, two populations of B cells
with high and low fluorescence were seen corresponding to
intracellular and extracellular OMV-FITC. To confirm the OMV
internalization by TEM, purified B cells were incubated with M.
catarrhalis for 1 h to allow the secretion of OMV. Figure 4E and 4F
show a B cell that has internalized at least two MID-containing
OMV in an endosome. Interestingly, the endosomes were coated
with IgD (large granules; white arrows). MID was also visualized
with a gold-labelled pAb (small granules; black arrows). As
expected, MID-deficient OMV were not taken up by the B
lymphocytes (results not shown). Taken together, the interaction
between MID and IgD induced OMV internalization by a
receptor mediated endocytosis.
M. catarrhalis OMV activate human tonsillar B cells
To evaluate the capacity of Moraxella OMV to activate human B
lymphocytes, freshly isolated tonsillar B cells were incubated with
OMV isolated from different strains of M. catarrhalis and analyzed
for [methyl-
3H]-thymidine incorporation after 96 h, using whole
bacteria killed by formaldehyde as a positive control [12]. In
contrast to OMV from MID-deficient mutants, only OMV
isolated from MID-expressing strains were found to have a similar
B cell stimulatory effect as compared to whole M. catarrhalis
(Fig. 5A). Any changes in B cell viability was not observed after
stimulation with the different Moraxella OMV preparations as
compared to B cells incubated with whole bacteria (Fig. 5B). OMV
isolated from the UspA1- and A2 deficient isogenic (but MID
expressing) control mutants did not interfere with B cell function.
The mitogenic effect of OMV containing the MID protein was
concentration dependent and saturated above 1.5 mg/ml (Fig. 5C).
To characterize the OMV-dependent B cell activation in detail,
supernatants from B cell cultures stimulated with OMV from the
M. catarrhalis wild type (wt) or the MID-deficient mutant were
analyzed using a human cytokine array containing antibodies
directed against different chemokines, interleukins (IL) and growth
factors, including IL-6, IL-10, tumor necrosis factor (TNF)-a, and
TNF-b. A strongly increased IL-6 production, up to 55-fold, was
detected when B cells were activated with the MID-containing
wild type OMV as compared to the MID-deficient OMV (Fig. 5D).
IL-8 secretion was found irrespectively of incubation with OMV as
compared to complete medium that was included as a negative
control. In addition, a minor up-regulation of IL-10 (3-fold
increase) and the chemokine growth regulated oncogene (GRO)
(2-fold increase) was also observed in cell cultures with OMV-
stimulated B lymphocytes.
To more precisely quantify the IL-6 concentrations in cultures
with OMV-stimulated B cells and compare the IL-6 response in
cultures with B cells activated in the presence of whole bacteria, an
ELISA was included in our analysis. Cell free supernatants from
different time points (24 to 96 h) were analyzed. The IL-6
synthesis reached a maximum after 48 h and did not change at
later time points (data not shown). As exemplified in Figure 5E,
OMV induced a strong IL-6 response at 48 h. MID-expressing
whole bacteria or the IgD-binding recombinant MID
962-1200
fragment [8,10] coated to the bottom of wells induced a similar
response suggesting that IgD cross-linking was the main factor for
IL-6 production. In parallel, IL-6 concentrations in B cell cultures
incubated with MID-deficient OMV or the mutant M. catarrhalis
Dmid were comparable with background values.
To determine whether OMV could induce Ig synthesis in
tonsillar B lymphocytes, supernatants from purified B cells
stimulated with Moraxella OMV were analyzed for Ig content by
ELISA (Fig. 5F–H). Cell free supernatants from B cells stimulated
with whole bacteria or recombinant MID
962-1200 were analyzed in
parallel as controls. Wild type OMV induced higher levels of IgM
production as compared to MID-deficient OMV (Fig. 5F),
whereas no differences were detected regarding IgG and IgA
synthesis (Fig. 5G and H). This indicated that the stimulation
induced by OMV was not enough to drive class switch
recombination (CSR). In parallel to the results on IL-6 (Fig. 5E),
only small variations in IgM production were detected between
MID-expressing whole M. catarrhalis bacteria and its derived OMV
(Fig. 5F). However, any secreted IgM was not detected in the other
supernatants including B cells activated with the recombinant
MID
962-1200 supporting previous observations that highlighted the
need for additional PRR signals or T cell-mediated help (CD40L
or cytokines) for optimal B cell activation [12–14].
The specificity of the OMV-induced antibodies was also tested
using a panel of the most dominant respiratory pathogens (M.
catarrhalis, non-typeable H. influenzae (NTHi), encapsulated H.
influenzae serotype b (Hib), and S. pneumoniae). Bacteria were
incubated with cell-free supernatants from OMV-stimulated B
cells and screened by flow cytometry for binding of IgM (Table 2)
and IgG (not shown). In agreement with our previous results with
whole Moraxella bacteria [14], no differences were detected
between specific antibody binding and background values to any
of the screened pathogens. These results suggested that OMV-
induced antibody production may not help the host to clear
Moraxella but merely redirects the humoral response.
A triggered BCR initiates a signaling cascade that leads to up-
regulation of co-stimulatory molecules. To examine the effect of
OMV on B cell surface molecules, purified tonsillar B cells were
incubated with OMV and screened by flow cytometry for HLA-
DR, CD69, CD86, and CD45 surface expression. As seen in
Figure 6A–D, only MID-containing OMV induced up-regulation
of these antigens and receptors. Thus, the B cell phenotype
induced by OMV was similar to the one observed in B cells
stimulated with whole M. catarrhalis [14].
B cell expression of certain TLRs is important in linking innate
and adaptive immune responses. Several studies have shown that
TLR9 is highly expressed in B cells [36,37]. It has recently been
demonstrated that peripheral blood B lymphocytes (CD19
+) can
be separated into two subsets consisting of TLR9
2 and TLR9
+
populations [38]. To study whether TLR9 expression was affected
by OMV, tonsillar B cells were examined by flow cytometry
analyses after OMV exposure. Stimulated lymphocytes were
permeabilized and double stained using RPE-conjugated anti-
CD19 and FITC-conjugated anti-TLR9 mAbs. Both TLR9
2 and
TLR9
+ subpopulations were found in the human tonsil B cell
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PLoS Pathogens | www.plospathogens.org 8 January 2010 | Volume 6 | Issue 1 | e1000724Figure 5. OMV containing MID activate tonsillar B cells. (A) The mitogenic effect of M. catarrhalis OMV isolated from different strains on B cells
was analyzed by measuring thymidine uptake at 96 h. Error bars indicating SEM from 6 different donors, * p#0.05, OMV versus control. (B) The
viability of B lymphocytes after OMV stimulation was assessed by trypan blue exclusion staining. (C) Purified B cells were stimulated with different
concentrations of OMV with or without MID (OMV Dmid), whole M. catarrhalis wild type or its isogenic mutant or recombinant MID
962-1200 as
indicated. The OMV concentrations used were in the range of 0.1–25 mg/ml. Error bars indicate SEM from 5 different donors. (D) OMV activated B cells
mainly produce IL-6. Purified B cells were incubated with 10 mg/ml OMV wild type (OMV wt) or MID-deficient OMV (OMV Dmid) for 96 h. Thereafter,
the cytokine contents in the B cell culture supernatants were determined using a human cytokine protein array. The protein microarray cut-off
controls are indicated as positive controls. Complete medium and a culture supernatant from unstimulated B cells were included as a negative
control. A minor up-regulation of IL-10 and GRO was also detected. (E–H) OMV binding to B cells induces IL-6 and IgM secretion. The stimulatory
effect of M. catarrhalis OMV on B cells was analyzed by measuring IL-6 secretion at 48 h (E) and IgM (F), IgG (G) or IgA (H) production at 96 h. B cells
were activated with 10 mg/ml OMV isolated from MID-expressing bacteria (wt) or a MID-deficient mutant (Dmid). In addition, whole M. catarrhalis wild
type (wt), its isogenic mutant (Dmid), or recombinant MID
962-1200 were included in the analysis. Error bars indicate SEM from 5 (E) and 3 (F–H) different
donors.
doi:10.1371/journal.ppat.1000724.g005
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subpopulations; low and high TLR9 expressing CD19
+ B
lymphocytes, which most likely illustrated the presence of different
stages of B cell differentiation in the tonsillar tissue. After 30 min
of incubation, however, 8762% of the CD19
+ cells incubated with
MID-containing OMV were TLR9
+ (Fig. 6F) as compared to
6763% of CD19
+ B cells in cultures exposed to OMV isolated
from the isogenic mutant M. catarrhalis Dmid (Fig. 6G). The
CD19
+TLR9
2 population that decreased in density after
activation is encircled in Figure 6E to G.
Intriguingly, it has been demonstrated that TLR9 can be
expressed at the cell surface of a subpopulation of tonsillar B cells
[39]. In that particular study, B cells positive for surface TLR9
expression represented a minor fraction of the total B cell
population, varying between 2 and 10%. We also detected a
minor surface TLR9
+ subset of tonsillar B cells (Fig. 6H). The
percentage of surface TLR9
+ B cells was 5.461.4 (mean
value6SD, n=3) of the total B lymphocytes relative to the isotype
control (0.460.9%). Lymphocytes stimulated for 30 min with
MID-containing OMV showed a two-fold higher cell surface level
of TLR9 (mean fluorescence intensity [mfi]: 715654 [mean
value6SD, n=3) than did MID-deficient OMV stimulated cells
(mfi, 360665) (Fig. 6H). To further analyse this phenomenon,
TLR9 transcripts levels in relation to the housekeeping gene b-
actin were measured using a quantitative real-time PCR.
However, despite an apparently higher level of TLR9 transcripts
observed in B cells stimulated with OMV as compared with B cells
activated with MID-deficient OMV, the difference was not
statistically significant (Fig. 6I). To summarize, in addition to a
change in the B cell surface phenotype upon stimulation with
OMV, the expression of the DNA receptor TLR9 increased.
OMV activate B cells via IgD BCR cross-linking and TLR9
signaling
The natural ligand for TLR9 is unmethylated CpG-DNA
motifs, which are primarily found in viral and bacterial DNA.
Previous studies demonstrated that OMV secreted by pathogenic
bacteria carry luminal DNA as well as DNA on their surface
[21,40,41]. To further investigate the role of TLR9 in Moraxella
OMV-induced B cell activation, we incubated human tonsillar B
cells with OMV isolated from bacteria grown in the presence of
DNase (‘‘OMV DNase culture’’) or OMV treated with DNase
after isolation (‘‘OMV DNase-treated’’) (Fig. 7A). Interestingly, a
synergistic effect was seen upon stimulation with a combination of
IgD (via OMV) and TLR9 (via genomic Moraxella DNA or the
synthetic TLR9 ligand CpG ODN 2006). The B cell proliferation
was significantly reduced with OMV isolated from bacteria that
had been cultured in the presence of DNase (Fig. 7A). Further-
more, B cell stimulation induced by OMV from DNase-treated
cultures was similar to the activation detected by preincubation of
B cells with antibodies directed against either the IgD BCR or
MID, which also inhibited the OMV-dependent B cell activation
by neutralizing the IgD cross-linking. Importantly, the presence of
genomic Moraxella DNA or CpG ODN 2006 restored the
proliferation induced by OMV isolated from DNase-treated
cultures and was comparable to the activation induced by DNA-
containing OMV. Finally, the B cell proliferation induced by
OMV was significantly reduced in the presence of the dominant
negative TLR9 inhibitory oligonucleotide (TTAGGG)64
(Fig. 7A).
The absence of DNA in OMV preparations from bacteria
growing in the presence of DNase was further confirmed by gold-
conjugated antibodies directed against DNA using TEM (Fig. 7B),
and by PCR amplification of the 16S rRNA gene of M. catarrhalis
(Fig. 7D). In contrast, DNA associated with OMV secreted by
untreated (i.e., no DNase supplemented) Moraxella cultures was
observed (Fig. 7C and D). Quantification of labelled DNA in the
TEM images revealed 39.4 gold particles/square micrometer in
untreated Moraxella cultures (Fig. 7C) as compared to 4.7 gold
particles/square micrometer in the DNase-treated cultures
(Fig. 7B). In conclusion, Moraxella OMV induced a B cell signal
via the IgD BCR, whereas the second signal was mediated via
TLR9 and DNA containing CpG-motifs associated with OMV.
Secretion of MID-containing OMV by M. catarrhalis in
vivo
To confirm that OMV released in vivo by M. catarrhalis also
contain MID, a nasal sample from a 9-year old child with newly
diagnosed M. catarrhalis sinusitis was examined by TEM using
gold-labelled antibodies directed against MID [9,42]. Figure 8A
shows one M. catarrhalis bacterium that released OMV containing
MID (black arrows) in vivo. The presence of DNA associated with
Table 2. Analysis of the specificity of IgM in supernatants from human B cells stimulated with OMV.
IgM
a in B cell supernatant
Species and strain nu unstimulated OMV wt stimulated OMV Dmid stimulated Control
b H serum
c
S. pneumoniae ATCC 6303 20.061.9 19.962.6 18.762.2 20.262.0 64.764.5
S. pneumoniae S6-2489 26.764.1 26.363.3 26.164.4 25.761.7 28.463.9
H. influenzae type b 41 17.663.1 19.064.0 17.663.7 20.963.5 30.762.4
H. influenzae type b 43 17.261.7 17.762.4 17.862.6 18.362.7 19.561.6
non-typeable H. influenzae 722 20.461.2 17.862.1 17.661.9 18.461.5 18.762.3
non-typeable H. influenzae 541 17.563.4 17.365.1 16.464.7 24.363.4 60.165.3
M. catarrhalis BBH18 26.261.7 22.962.5 24.663.1 27.362.8 36.864.2
M. catarrhalis KR 923 24.662.1 23.961.6 25.661.9 26.663.6 42.665.2
aAverage values of mean fluorescence intensity6SEM from three independent experiments with separate tonsil donors. Bacteria were incubated with supernatants
from B cell cultures as indicated followed by incubation with FITC-conjugated rabbit anti-human IgM and flow cytometry analyses.
bThe negative control consisted of complete culture medium (RPMI 1640) without human serum and was used as a control for unspecific binding of the FITC-
conjugated rabbit anti-human IgM.
cComplete culture medium (RPMI 1640) supplemented with a pool of human sera to a final dilution of 1/1,000 was used as a positive control.
doi:10.1371/journal.ppat.1000724.t002
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using gold-labelled anti-DNA antibodies (Fig. 8B; white arrows).
To ensure that MID and DNA were located on the same OMV,
double staining was performed (Fig. 8C). Large granules indicate
MID (black arrows), whereas small granules show DNA (white
arrows). Thus, each OMV released in vivo in a 9-year old child
contained the protruding MID molecule in addition to DNA
adjacent to the OMV surface.
We also isolated this particular strain, designated M. catarrhalis
KR971, from the child with sinusitis. Importantly, the clinical
isolate was only passed once and immediately frozen. To evaluate
the capacity of OMV secreted by this isolate to interact with B
cells in vitro, OMV isolated from an overnight liquid culture were
labelled with FITC and incubated with purified tonsillar B
lymphocytes. OMV secreted by M. catarrhalis KR971 clearly
bound to B cells when analyzed by flow cytometry, whereas
OMV isolated from the isogenic MID-deficient mutant M.
catarrhalis BBH18 Dmid, which were included as a negative
control, did not (Fig. 8D). Finally, the presence of MID in OMV
released in vitro was also confirmed by SDS-PAGE and Western
blot using pAbs directed against the IgD-binding region of MID
(Fig. 8E).
Figure 6. OMV cause up-regulation of B cell surface markers. OMV induced changes in expression of HLA-DR (A), CD86 (B), CD69 (C) and
CD45 (D). Surface expression of B cell activation markers after OMV stimulation was analyzed by flow cytometry. Unstimulated B cells are shown as
filled profiles (gray) and B cells incubated with OMV wt (left panels) or MID-deficient OMV (OMV Dmid, right panels) are indicated as white profiles.
Representative results from one out of three donors are shown. (E–G) Flow cytometry analysis of TLR9 expression in B cells stimulated with OMV.
Purified B cells were either unstimulated (E) or incubated with 10 mg/ml of OMV-wt (F) or OMV-Dmid (G) for 30 min. Thereafter, B cells were double
stained with RPE-conjugated anti-CD19 and FITC-conjugated anti-TLR9 mAbs followed by flow cytometry analysis. In panels (E) to (G), the TLR9-
negative CD19
+ B cell population is encircled to illustrate the CD19
+TLR9
2 population that decreased after stimulation. Data are representative for 3
similar profiles obtained from separate donors. (H) Flow cytometry analysis of surface TLR9 expression in OMV-stimulated B cells. Unstimulated B cells
are shown as a grey profile. B cells stimulated with OMV wt or MID-deficient OMV for 30 min are shown as dark black and blue line profile,
respectively. Isotype control Ab-labelled B cells are shown as a red line profile. One representative histogram is shown out of three independent
experiments. (I) Relative levels of TLR9 transcripts in OMV-stimulated human tonsillar B cells. Purified B cells were either unstimulated (control)o r
incubated with 10 mg/ml OMV wild type (OMV wt) or MID-deficient OMV (OMV Dmid) for 30 min. Expression levels were determined using
quantitative real-time reverse transcription-polymerase chain reaction (RT-PCR) and are depicted in relation to the internal control gene, b-actin, as
2
DCt610
5. Data from experiments with cells from 3 different donors are summarized and presented as mean6SEM.
doi:10.1371/journal.ppat.1000724.g006
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Moraxella-induced T-independent B cell activation is initiated by
IgD cross-linking via the superantigen MID [13]. Moreover, PRRs
like TLR also play an important costimulatory role in superan-
tigen-dependent B cell activation since signaling via TLR2 and
TLR9 is required for a maximal B cell response induced by MID-
expressing bacteria [13]. B cell activation induced by Moraxella
results in the production of polyclonal IgM, and these antibodies
are not directed against Moraxella suggesting an important role for
MID in M. catarrhalis pathogenesis [14]. We have previously
demonstrated that the interaction between MID and IgD also
mediates tonsillar B cell endocytosis of whole bacteria. This
prompted us to investigate whether tonsillar B cells constitute a
potential niche for M. catarrhalis. However, despite MID expression
was required for B cell uptake, Moraxella did not survive after it had
been endocytosed by tonsillar B cells (Fig. 1). Furthermore,
physiological concentrations of soluble IgD did not block the
binding of Moraxella to human B cells probably due to the high
density of MID at the bacterial surface [9,42]. It is generally
accepted that primary B cells are nonphagocytosing cells, albeit
recent findings challenge this concept. Souwer et al. found that
human B cells are able to internalize Salmonella typhimurium when
bacteria are recognized by the BCR [43], but in contrast what was
observed with Moraxella, Salmonella survives intracellularly
[44,45]. The exact mechanism how B cells kill Moraxella is not
clear at present, but fusion of early endosome-containing bacteria
with the phagolysosome compartment may be a possibility. The
IgD-mediated endocytosis of whole bacteria by tonsillar B cells is a
unique uptake mechanism related to the IgD-binding Moraxella
only. Despite that the uptake might be a disadvantage for the
bacteria, M. catarrhalis-induced B cell proliferation may further
increase the number of bacteria that are taken up and processed,
but at the same time leading to a polyclonal antibody production
with antibodies that are not directed against the bacterial species
as such. More studies are required to fully understand the final
outcome of this process.
MID is a highly conserved outer membrane protein and the mid
gene can be detected in essentially all clinical M. catarrhalis isolates
[42]. The IgD-binding domain of MID is only located within 238
amino acids at the distal end of the surface exposed MID molecule,
which consists of a total of approximately 2,200 amino acids. Thus,
M. catarrhalis could potentially remove the IgD binding domain and
hence the capacity to bind B cells within a few cell generations
[8,9,42]. Although the exact function of MID-dependent IgD-
binding during Moraxella pathogenesis still remains elusive, it is most
likely that this unique virulence factor plays a significant role in
determining the success of Moraxella colonization and/or infection.
To further shed light upon the intriguing IgD-binding capacity
of M. catarrhalis, we focused on OMV that are commonly secreted
by Gram-negative bacteria including this species. We have
previously demonstrated that Moraxella OMV can neutralize C3
and hence pave the way for the respiratory pathogen Haemophilus
influenzae when exposed to the bactericidal effect of human serum
[25]. In the present study, we show the presence of MID in
secreted M. catarrhalis OMV both in vitro liquid culture of Moraxella
(Fig. 2) and in a nasal sample from a child newly diagnosed with
M. catarrhalis sinusitis proving the existence of MID-containing
OMV in vivo (Fig. 8). OMV binding to human tonsillar CD19
+
IgD
+ lymphocytes by the superantigen MID results in vigorous
activation. The interaction between tonsillar B cells and Moraxella
OMV induced a phenotypic change in B cells including down-
regulation of IgD followed by upregulation of surface antigens. In
parallel with the B cell response observed after stimulation with
Figure 7. TLR9 participates in OMV-dependent B cell activa-
tion. (A) B cell proliferation was measured by means of [methyl-
3H]-
thymidine incorporation after 96 h. OMV from the MID-expressing M.
catarrhalis wild type (OMV) were combined with different additives as
indicated in the figure. OMV isolated from M. catarrhalis growing in
presence of DNase (OMV DNase culture) and OMV treated with DNase
after isolation (OMV DNase-treated) were also included. The viability of
B lymphocytes after each treatment was measured by trypan blue
exclusion staining. Error bars indicate SEM from 5 different donors. The
presence of DNA associated with OMV from DNase treated bacterial
culture (B) or untreated culture (C) were analyzed by TEM using gold
labelling anti-DNA pAb. (D) The presence of DNA associated with OMV
was confirmed by PCR. DNA extractions from OMV DNase-treated or
untreated samples were used as template for amplification of the
genomic 16S rRNA gene. M. catarrhalis genomic DNA was used as a
positive control and an ultracentrifuge supernatant (free of bacteria and
OMV) from DNase treated and untreated cultures were also analyzed to
check the presence of extracellular DNA. Representative images from
three independent experiments are shown. * p#0.05, OMV DNase-
treated versus OMV and OMV DNase-treated + genomic DNA versus
OMV DNase-treated; ** p#0.01, OMV versus unstimulated cells.
doi:10.1371/journal.ppat.1000724.g007
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increase of the IgM production in the absence of physical T cell
help or cytokines. No differences in IgG or IgA production were
observed after B cell stimulation with OMV isolated from the wild
type or the MID-deficient mutant suggesting that OMV activation
alone was not enough to drive CSR. In agreement with these
results, experiments using a combination of native MID, CD40L,
IL-4, and IL-10 only resulted in low IgG and IgA production [2].
The absence of antibody specificity directed against the most
dominant respiratory pathogens indicated that the OMV-depen-
dent B cell response may not help the host to clear the respiratory
pathogens but suggests that Moraxella merely redirects the humoral
response that would be beneficial for bacterial colonization.
Finally, the strong mitogenic effect on B cells induced by MID-
containing OMV in addition to what was previously shown with
whole bacteria suggests that pathogen-associated molecular
patterns (PAMPs) needed for full B cell activation are present in
the OMV [12–14]. The main PAMP involved in the B cell
activation induced by OMV was bacterial DNA that was
associated with OMV and activates the intracellular PRR
TLR9. An interesting observation is that several bacterial species
including M. catarrhalis have the capacity to form biofilms and in
some cases biofilms are largely built up by OMV [46]. The biofilm
offers the bacterium a protective coat against phagocytosis [47].
Another important cornerstone of biofilms is that DNA is secreted
during growth and it has been shown that Pseudomonas aeruginosa
cannot form biofilms when grown in the presence of DNase I [48].
OMV secreted by Moraxella during infection contain biologically
active molecules which are effective in activating immune host
cells and thus represent a potential novel virulence mechanism. It
remains, however, to delineate the role of OMV and DNA in
Moraxella biofilm formation.
Vesicles secreted by Moraxella have the capacity to bind tonsillar
B cells, and the superantigen MID is responsible for this
phenomenon. Binding of OMV followed by internalization into
B cells depend specifically on the interaction between MID and
surface expressed IgD BCR. TEM analysis with antibodies
directed against MID demonstrated that Moraxella OMV con-
tained several MID molecules capable of cross-linking multiple
IgD BCR needed for B cell stimulation. Several examples of OMV
surface factors which mediate adhesion to and invasion of
eukaryotic cells have been identified in other pathogens. For
example, LPS-bound heat labile enterotoxin (LT) is the adhesin
responsible for enterotoxigenic Escherichia coli OMV interactions
with host cells [22,49]. Borrelia burgdorferi, the spirochete responsible
for Lyme disease, produces OMV that bind to endothelial cells
through the outer membrane proteins OspA and OspB [23].
Another example is OMV from Shigella flexneri that adhere to and
enter human intestinal cells in vitro via the outer membrane
invasins IpaB, C and D [20].
The MID-dependent OMV binding leads to Ca
2+-mobilization
and clustering of receptors in lipid raft motifs in purified B cells.
Figure 8. M. catarrhalis OMV secreted in vivo contain MID and DNA. A clinical sample from a 9-year old patient was analysed and TEM showed
the presence of MID (A) and DNA (B) on OMV. In (C) MID and DNA associated with OMV is marked with gold-labelled antibodies against MID (large
granules, black arrows) and DNA (small granules, white arrows). The scale bar in (A–C) represents 100 nm in length. (D) Representative flow cytometry
profiles of FITC-labelled OMV isolated from the clinical isolate M. catarrhalis KR971 (white) as compared to OMV from the MID-deficient M. catarrhalis
BBH18 Dmid (shaded) when bound to purified tonsilar B lymphocytes. OMV were used at 10 mg/ml and incubated with B cells for 1 h at 37uC. (E) MID
expression in OMV isolated from the clinical isolate of M. catarrhalis was analyzed by SDS-PAGE (Ag-stain) and Western blot (WB) using MID specific
rabbit pAbs. Molecular weight markers in kilodalton are indicated to the left.
doi:10.1371/journal.ppat.1000724.g008
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mediated signal transduction (for a review see [32]). The
functional significance of lipid raft aggregation induced by
OMV was most likely to enhance BCR signaling. Gupta et al.
[31] have shown that BCR stimulation recruited the tyrosine
kinase Syk to lipid rafts and induced concentrated protein tyrosine
phosphorylation in the proximity of lipid rafts indicating that BCR
signaling is occurring primarily within this compartment. We
confirmed the involvement of lipid raft structures in OMV-
induced clustering of receptors by testing the effects of filipin,
which disrupts lipid motifs. The mobilization of IgD, TLR2, and
TLR9 into lipid rafts appeared to be cholesterol dependent, as its
localization to specific lipid raft fractions was lost in B cells treated
with filipin. A previous study has shown that the association
between E. coli OMV and host epithelial cells is also sensitive to
treatment with filipin [22]. More recently, Bomberger et al.
demonstrated that P. aeruginosa OMV deliver multiple virulence
factors into host airway epithelial cells via a mechanism of OMV
fusion with the lipid raft machinery [24]. In parallel with that
study, we suggest in the present paper that OMV-mediated fusion
of virulence factors via lipid raft domains is a common strategy of
Gram-negative bacteria to interact with the human host.
The signaling through the BCR is noticeably regulated by an
array of signaling receptors receiving information from the
surrounding milieau of the B cells [50]. In fact, receptors of the
innate immune system, in particular TLRs, have shown to
influence the result of antigen engagement by the BCR [51,52].
CpG DNA-induced TLR9 signaling has been demonstrated to
synergize with antigen-induced BCR signaling and this synergistic
engagement has been implicated in the activation of autoimmune
B cells [53,54]. Recently, Chaturvedi et al. [55] demonstrated that
the internalized BCR signals recruit TLR9-containing endosomes
to the autophagosome and this recruitment showed to be
necessary for the B cell hyperresponses. In agreement with these
results, we found that OMV induced a strong B cell activation via
TLR9 signaling indicating that DNA-containing OMV affect B
cell responses and that the modulating effects of TLR9 on
downstream BCR signaling events are required for full activation
of B cells. After 30 min of incubation with DNA-containing OMV
the internalized BCR colocalized TLR9 and Rab5 in early
endosomes (Fig. 3D). Relocalization of TLR9 into intracellular
structures has been previously shown in mouse B cells after
crosslinking of the BCR with anti-IgM pAb conjugated to CpG-
containing DNA [55]. These authors proposed a model for B cell
hyperresponses to DNA containing antigen in which antigen
internalization and BCR signaling recruit TLR9 to autophago-
some-like compartments to allow TLR9 to survey the antigen for
its DNA ligand. In the case of DNA-containing OMV secreted by
pathogenic bacteria, the enhanced signaling through the BCR and
TLR9 may contribute to unspecific antibody production by
reducing the threshold for B cell activation. Interestingly, we were
able to detect both intracellular and extracellular upregulation of
TLR9 expression in OMV-stimulated B cells. Surprisingly, no
increase in TLR9 transcripts was observed. Regulation of
eukaryotic mRNA translation is a fundamental mechanism for
moderating cellular events, and micro-RNAs (miRNAs) play
important roles in a wide range of biological events through post-
transcriptional suppression of target mRNAs. Recent data
demonstrate that miRNAs regulate TLR2 and TLR4 expression
[56,57], and the impetus for future studies would be to clarify the
post-trancriptional TLR9 regulation in human B cells upon
activation through the IgD BCR.
In conclusion, our results demonstrate that OMV secreted by
M. catarrhalis have the capacity to induce a T cell independent B
cell activation by the IgD-binding MID in addition to the PRRs
TLR2 and TLR9 (Fig. 9). Moraxella OMV can therefore mediate
host interactions at a distance from the site of colonization,
conferring serum resistance [25] and a delayed specific antibody
response not only to M. catarrhalis but most likely also to other
bacterial species such as pneumococci and H. influenzae that are
dwelling in the respiratory tract.
Materials and Methods
Antibodies and reagents
Rabbit anti-human IgD, fluorescein isothiocyanate (FITC)-
conjugated rabbit anti-human IgM or IgD, R-phycoerythrin
(RPE)-conjugated rabbit anti-human IgD polyclonal antibodies
(pAbs), RPE-conjugated mouse anti-human CD3, CD14, CD16,
CD19, CD45, CD56, CD83 monoclonal antibodies (mAbs),
FITC-conjugated mouse anti-human CD19, CD86, CD69 and
HLA-DR mAbs were purchased from DAKO (Glostrup, Den-
mark). Mouse anti-human TLR9 mAbs were supplied by
InvivoGen (San Diego, CA). FITC-conjugated mouse anti-human
TLR9 and anti-human TLR2 mAbs were obtained from Imgenex
(San Diego, CA). Mouse anti-flotillin-2, mouse anti-caveolin-1 and
mouse anti-Rab5 mAbs were purchased from BD Bioscience (San
Diego, CA). The truncated recombinant MID
962-1200 and
MID
1000-1200 fragments, and rabbit anti-MID
962-1200 antiserum
were prepared as described earlier [10,58]. Filipin III was
purchased from Sigma-Aldrich (St. Louis, MO). The TLR ligands
CpG ODN 2006 and the suppressive oligonucleotide (ODN) with
human-specific CpGs (TTAGGG)64 were supplied from Invivo-
gen. Alexa Fluor 488 goat anti-mouse IgG, Alexa Fluor 594 goat
anti-mouse IgG, Alexa Fluor goat anti-mouse 633, Alexa Fluor
546 goat anti-rabbit IgG and ProLong Gold antifade reagent with
DAPI (49, 6-diamidino-2-phenylindole) were purchased from
Molecular Probes (Invitrogen, Carlsbad, CA). Purified IgD from
human serum was obtained by affinity chromatography as
described earlier [59].
Bacterial strains and growth conditions
The M. catarrhalis strains used in this study are described in
Table 1. Bacteria were routinely cultured in brain heart infusion
(BHI) liquid broth or on BHI agar plates at 37uC. M. catarrhalis
BBH18 mutants were previously described [42,58,60]. The MID-
deficient mutants were cultured in BHI supplemented with 50 mg/
ml kanamycin. A set of UspA1 and A2 deficient mutant was also
included as controls. The UspA1-deficient mutant was cultured in
BHI supplemented with 1.5 mg/ml chloramphenicol (Sigma-
Aldrich), and the UspA2-deficient mutant was incubated with
7 mg/ml zeocin (Invitrogen). Both chloramphenicol and zeocin
were used for growth of the UspA1/A2 double mutants. Genomic
M. catarrhalis DNA from the BBH18 wild type strain was extracted
using the DNeasy kit (Qiagen, Hilden, Germany) according to the
manufacturer’s recommendations. Purified DNA was free of
contaminants and enzyme inhibitors.
Isolation of outer membrane vesicles and DNA analysis
OMV were prepared from overnight cultures according to the
Rosen method [61]. Briefly, cell free supernatants were filtered
through a 0.2 mm-pore size filter (Sartorius, Epson, UK) and
concentrated using 100 kDa Vivaspin centrifugal concentrators
(Vivascience, Hannover, Germany). The concentrated superna-
tants were thereafter centrifuged at 100,0006g for 60 min. The
precipitates containing OMV were washed three times in PBS
followed by a final sterile filtration to exclude cellular contam-
ination from the parent OMV-producing M. catarrhalis. Protein
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(NanoDrop Technologies, Wilmington, DE). The purity of OMV
samples was examined by transmission electron microscopy
(TEM) and by excluding bacterial growth of any remaining
parent cells on BHI agar. To evaluate a putative uptake of
exogenous DNA encapsulation by OMV, a DNase assay was
performed as previously described by Renelli et al. [21]. Briefly,
two Ehrlenmeyer flasks were inoculated with M. catarrhalis
BBH18, one was the control and one was supplemented with a
final concentration of 100 mg DNase/ml (Sigma) and 10 mM
MgCl2 (‘‘OMV DNase culture’’). Flasks were incubated at 37uC
(200 r.p.m.) until late exponential phase followed by OMV
isolation. The uptake of DNA within OMV in the presence of
DNase was examined by PCR and TEM as described below.
DNA extraction using DNeasyH Blood & Tissue kit (Qiagen) was
performed on untreated OMV and DNase treated OMV. The
final ultracentrifuge supernatant (free of bacteria and OMV) from
both cultures was analyzed to determine whether extracellular
DNA was present. Whole cell genomic DNA was included as a
positive control. Samples containing DNase were heated at
100uC for 15 min before being analyzed by PCR according to a
standard protocol. DNA primers used for the amplification of the
M. catarrhalis 16S rRNA gene were 59-GCCCTGACGTTACC-
CACA-39 and 59-TCACCGCTACACCTGGAA-39. PCR am-
plification consisted of a 3 min hot start of 95uC followed by 30
cycles of 45 sec. at 95uC, 30 sec. at 54uC and 15 sec. at 72uC.
The reaction was completed with an extension step of 5 min at
72uC. In experiments with DNase-treated OMV, preparations
were treated with 50 mg/ml DNase I (Sigma) in 10 mM MgCl2 to
digest putative DNA bound to the outer surface of OMV. After
incubation for 1 h at 37uC, the OMV were washed twice with
PBS by ultracentrifugation followed by heat inactivation at
100uC.
SDS-PAGE and Western blots
The protein content of OMV was analyzed on a 10% SDS-
PAGE stained with BioRad Silver Stain Plus kit (Munich,
Germany). Proteins were transferred at 20 V overnight to an
Immobilon-P membrane (Millipore, Bedford, MA). After transfer,
the membranes were blocked for 2 h using PBS with 0.1% Tween
(PBS-Tween) and 5% skim milk powder. After several washes with
PBS-Tween, the membrane was incubated with a rabbit anti-
MID
962-1200 antiserum as described [10,58]. Repeated washes
with PBS-Tween were followed by incubation with horseradish
peroxidase (HRP)-conjugated goat anti-rabbit pAbs (Dakopatts,
Copenhagen, Denmark) in PBS-Tween including 2% skim milk
for 45 min. The transferred proteins were detected using ECL
Western blot detection reagents (Amersham Pharmacia Biotech,
Uppsala, Sweden).
Figure 9. Cartoon schematically showing M. catarrhalis OMV-dependent B cell activation. OMV discharged from Moraxella are taken up by
B cells via an IgD-mediated cross-linking and endocytosis. A signal is induced via the MID-mediated contact with the IgD B cell receptor followed by
formation of lipid rafts. In addition, TLR2 colocalize in lipid raft motifs and participate in the signaling induced by OMV. In the endosome, DNA-
containing OMV are activating TLR9. The IgD BCR and TLR2/9 mediated signaling results in IL-6 production and eventually IgM secretion.
doi:10.1371/journal.ppat.1000724.g009
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Tonsils (n=16) were obtained from patients under the age of 12
(age range: 3–12 years old) undergoing tonsillectomy at the
University Hospital in Malmo ¨. The Ethics Committee of Lund
University approved the study (No. 877/2005) and a signed
written informed consent was obtained from the parents (or legal
representatives) of all patients. Surgery was performed due to
tonsillar hyperplasia and apart from the tonsillar symptoms, all
patients were healthy and did not receive any medication. Tonsils
were dissected in RPMI 1640 medium supplemented with 10%
FCS, 2 mM glutamine, 50 mg/ml gentamicin and 100 U/ml
penicillin (complete medium). The homogenized cell suspensions
were filtered through a 70 mm nylon cell strainer (Becton
Dickinson, NJ) followed by isolation of lymphocytes on Lympho-
prepH (Nycomed, Oslo, Norway) density-gradients as described
[10]. Untouched CD19
+ B cells were isolated by an indirect
magnetic labelling system (B Cell Isolation Kit II; Miltenyi Biotec,
Bergisch Gladbach, Germany) with an additional purification step
using magnetic labelled antibodies directed against CD3 (Miltenyi
Biotec) resulting in an ultrapure B cell preparation (99%$CD19
+).
B cells were routinely screened for contaminating monocytes, T
cells, NK cells, or dendritic cells using RPE-conjugated mAbs
against CD3, CD14, CD16, CD56, or CD83 in combination with
FITC-conjugated anti-human CD19 mAbs after isolation and
during culture. In all experiments with lymphocytes, 1610
6 cells/
ml were cultured in complete medium supplemented with various
reagents in culture plates (Nunc, Roskilde, Denmark). OMV from
BBH18 strains were added at concentrations ranging from 0.1–
25 mg/ml. The TLR ligand CpG ODN 2006 and the dominant
negative TLR9 ligand (TTAGGG)64 were added at 1 mM and
8 mM, respectively. The IgD binding part of MID (MID
962-1200)
was as previously described [58] and coated in Tris-HCl buffer
(pH 9.0) overnight. Proliferation was measured by [methyl-
3H]-
thymidine incorporation (1 mCi/well, Amersham Pharmacia
Biotech) using an 18 h pulse period. B cell viability after each
treatment was routinely assessed by trypan blue exclusion staining.
Intracellular survival assay
To examine bacterial intracellular survival on purified tonsillar
B lymphocytes, we used a modification of the method described by
Slevogt et al. [62]. M. catarrhalis BHH18 wild type or the
corresponding mutant BBH18 Dmid were resuspended in PBS
and added to 1610
5 B cells at multiplicity of infection (MOI) of
100 followed by incubation at 37uC and 5% CO2 for 1 h. After
several washes, infected B cells were incubated in RPMI 1640
medium containing 200 mg/ml gentamicin for 1 h to kill
extracellular bacteria. Subsequently, infected B cells were washed
three times with PBS and resuspended in RPMI 1640 medium
followed by incubation at 37uC. The number of viable
intracellular bacteria was determined after 0–4 h of further
incubation. To lyse the lymphocytes and release M. catarrhalis,
infected cells were resuspended in 1 ml PBS and transferred to a
glass tube containing glass pearls to mechanically lyse the cells by
vigorous vortex for 1 min. An aliquot of lysed cells was serially
diluted and quantitatively plated on BHI agar plates. Colony
forming units (cfu) were counted after 24 h of incubation at 37uC.
No changes in the number of viable lymphocytes were detected
upon infection. Control experiments to assess efficacy of antibiotic
bactericidal activity were performed in parallel. Briefly, samples of
1610
8 bacteria were incubated with RPMI 1640 medium
containing gentamicin and plated on BHI agar after 1 h at
37uC. This treatment resulted in complete killing as judged by
colony forming units (cfu).
Measurement of Ca
2+ mobilization
Ca
2+ mobilization was measured with Fura-2 according to the
following protocol. Purified lymphocytes were resuspended at a
density of 10
7/ml in HBSS (Hank’s balanced salt solution)-1%
BSA buffer (Gibco, Invitrogen Cell Culture) and incubated in a
waterbath at 37uC in the presence of 2 mM Fura-2 AM (Molecular
Probes, Eugene, OR), followed by two washes in the above
medium. The Fura-2 loaded cells were then resuspended at a
density of 2610
6/ml in a optical methacrylate (PMMA) disposable
cuvettes (Kartell; Merck, Poole, UK) in 2 ml of HBSS-1% BSA
buffer. Ca
2+ mobilization into the cytosol was monitored at 340
and 380 nm (excitation) and 510 nm (emission) with a spectroflu-
orimeter (FluoroMax, Spex Industries, Edison, NJ) using the
dM3000 Software. Ca
2+ concentrations were calculated using the
Grynkiewicz equation [63]. For the stimulation of B cells, OMV
(10 mg/ml) and ionomycin (100 nM) (Sigma-Aldrich) were added
at 50 sec. after the start of data acquisition.
Isolation of lipid rafts
A modification of the method of Brown et al. was used to isolate
lipid rafts [64]. Tonsillar B cells were exposed to M. catarrhalis
(1610
7 CFU/ml) or OMV (10 mg/ml) for 30 min and/or filipin
20 mg/ml for 30 min prior to stimulation. The cells were washed
with cold PBS and lysed with 0.5% Triton X-100 in TNE buffer
(25 mM TrisCl, pH 7.5, 150 mM NaCl, and 5 mM EDTA) plus
protease inhibitors for 20 min on ice. Lysed cells were harvested
and homogenized with a loose-fitting followed by a tight-fitting
Dounce homogenizer. Whole cells and nuclei were removed by
centrifugation at 1,0006g for 10 min. An equal volume of 90%
sucrose in TNE buffer was added to the supernatant. This 45%
layer was overlaid with 30% and 5% sucrose in TNE buffer to
form a discontinuous gradient. Samples were centrifuged at
200,0006g for 18 h at 4uC followed by collection of 1 ml
fractions. Protein concentrations were determined using a
NanoDrop and 5 mg was analyzed on a 12% SDS-PAGE. After
transfer to PVDF Immobilon-P (Millipore), blots were incubated
in 5% skim milk blocking solution for 1 h at room temperature
(RT). HRP-conjugated anti-goat or anti-mouse IgG (DAKO) and
Western Lightning Chemiluminescence Reagent Plus (Perkin
Elmer Life Sciences, Boston, MA) were used for visualization.
Flow cytometry analyses
Surface expression of IgD and IgM after addition of OMV was
monitored using flow cytometry (Becton Dickinson, Franklin
Lakes, NJ). Purified B cells were incubated in complete medium
with different concentrations of OMV ranging from 0.625–10 mg/
ml and analyzed for IgM and IgD expression at various time
points (0–24 h). Harvested cells were washed and incubated in
PBS containing 2% BSA with FITC-conjugated rabbit anti-
human IgM and RPE-conjugated rabbit anti-human IgD pAb for
1 h on ice. After two washes in PBS, B cells were screened for IgM
and IgD density using flow cytometry. The internalization of IgD
after stimulation with OMV was also examined by flow cytometry.
Purified tonsillar B cells were stimulated with wild type or MID-
deficient OMV, fixed and incubated with FITC-conjugated anti-
CD19 mAb and rabbit anti-IgD pAb to block surface expressed
BCR. After several washes, B cells were incubated in permeabi-
lization buffer (0.03% Triton X-100 and 5% normal serum
blocking solution in PBS) followed by incubation with RPE-
conjugated anti-IgD mAb. The B cell surface phenotype changes
after exposure to OMV was also investigated using flow cytometry
analysis. Stimulated B cells were harvested in PBS-BSA and
labelled with antibodies directed to different surface markers for
1 h on ice. For TLR9 screening, B cells stimulated with OMV
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washing steps, cells were incubated in permeabilization buffer
(0.03% Triton X-100 and 5% normal mouse serum blocking
solution in PBS) before adding FITC-conjugated anti-TLR9
mAbs. For extracellular TLR9 screening, B cells stimulated with
Moraxella OMV were fixed and stained with FITC-conjugated
anti-TLR9 mAbs.
The ability of purified human IgD to block M. catarrhalis binding
to B cells was also tested by flow cytometry experiments. FITC-
labelled M. catarrhalis wild type were treated with increased
concentration of purified human IgD (0–150 mg/ml) for 1 h. After
several washes, bacteria were incubated with purified human B
cells for 30 min at 37uC followed by washes. Bacterial binding to B
cells were assessed by flow cytometry. In order to corroborate that
the purified human IgD bound to FITC-labelled M. catarrhalis,
bacteria were incubated with human IgG standard (50 mg/ml) or
purified IgD (50 mg/ml). After several washes, bacteria were
incubated with an RPE-conjugated anti-human IgD mAb and
analyzed by flow cytometry.
Binding of FITC-stained OMV to B cells was also tested.
Briefly, 2610
5 purified B cells were incubated with 10 mg/ml
FITC-stained OMV from M. catarrhalis wt or Dmid for 1 h at 37uC.
B lymphocytes were washed twice with PBS before analysis. To
distinguish between intracellular and extracellular FITC-stained
OMV, we used a fluorescence quenching method as described
[35]. The quenching dye was prepared as follows: trypan blue
(2 mg/ml; Merck) was dissolved in 0.15 M NaCl in 0.02 M NaAc
buffer (pH 4.4) containing crystal violet (2 mg/ml; Merck). The
quenching dye was added to the cells previously incubated with
FITC-stained OMV directly before flow cytometry analysis.
Cytokine protein Array, IL-6 and Ig ELISA
To analyse cytokine production, 1610
6 purified tonsillar B cells
were cultured with or without 10 mg/ml OMV in 12-well flat-
bottom plates (Nunc-Immuno Module) in a final volume of 1 ml
complete medium. The cell-free supernatant was harvested after
96 h, and the cytokine protein arrays were performed according to
the manufacturer’s instructions (RayBio Human Cytokine Anti-
body Array, RayBiotech, Norcross, GA). IL-6 production was
determined using enzyme-linked immunosorbent assay (ELISA)
plates from R&D systems (Minneapolis, MN). IgG, IgA and IgM
were measured in cell free B cell supernatants harvested after 96 h.
ELISA plates (Maxisorb, Nunc) were coated at 4uC overnight with
rabbit anti-human IgG, IgA or IgM pAb (Dakopatts) in 0.1 M
Tris-HCl (pH 9.0). The plates were washed four times with PBS-
Tween followed by 2 h blocking at RT using PBS-Tween
supplemented with 1.5% ovalbumin HRP-conjugated rabbit
anti-human IgG, IgA or IgM (Dakopatts) pAb, respectively, that
were used as detection antibodies. Finally, the plates were
developed and measured at OD450. A standard serum (Dakopatts)
was included for calculation of the Ig concentrations.
Fluorescence, confocal and transmission electron
microscopy
For fluorescence and confocal microscopy, B cells (1610
6) were
incubated with OMV (10 mg/ml) in 1 ml complete medium for
30 min at 37uC. After several washes with ice cold phosphate-
buffered saline (PBS), cells were fixed with 4% paraformaldehyde
solution for 10 min at RT, washed and incubated with 5% normal
serum blocking solution for 20 min at RT. Primary antibodies
were added for 1 h at RT followed by three washes. For TLR9
staining, cells were fixed and incubated in permeabilization buffer
(0.03% Triton X-100 and 5% normal serum blocking solution in
PBS) before adding anti-TLR9 mAbs. Alexa Fluor-conjugated
secondary antibodies were incubated in the dark for 1 h at RT.
For the triple staining procedure, stimulated B cells were fixed,
permeabilized as described before and incubated with rabbit anti-
IgD pAb (BCR) and mouse anti-Rab5 mAb (Rab5) for 1 h at RT.
After several washes, B cells were incubated with Alexa Fluor 633
goat anti-mouse IgG and Alexa Fluor 546 goat anti-rabbit IgG
secondary mAb followed by incubation with FITC-conjugated
anti-TLR9 mAb (TLR9). After washing twice with PBS, cells were
resuspended in 50 ml of PBS, of which 15 ml was transferred to
polylysin glass slides and allowed to sediment for 15 min at RT.
The cells were fixed to the glass surface with DAPI containing
Prolong Gold antifade reagent overnight and examined by
immunofluorescence microscopy or by confocal microscopy using
a Bio-Rad Radiance 2000 confocal system fitted on a Nikon
microscope with a660/NA 1.40 oil lens. B lymphocytes showing
polarization of lipid rafts were counted by microscopic examina-
tion of 25 randomly selected fields, showing a minimum of three B
cells per field. Cells showing signs of clustering were expressed as
percentage of the total number of cells per field.
For immunohistochemistry and TEM, B cells (1610
6) were
incubated with 5610
7 M. catarrhalis wild type in 1 ml complete
medium for 1 h at 37uC, followed by centrifugation and fixation in
TEM fixative. Alternatively, bacteria from cultures untreated or
DNase treated were centrifuged and fixed. A fresh nasal discharge
from a 9-year-old child with M. catarrhalis sinusitis (pure growth of
Moraxella on nasal aspirate culture) was also examined. This was
prepared by suspending a drop of the purulent nasal discharge in
1 ml of PBS with 4% paraformaldehyde. The cellular fraction was
obtained by centrifuging the specimen at 2146g. Aliquots were
thereafter examined by TEM. Ultrathin sections were mounted on
gold grids and subjected to antigen retrieval using sodium
metaperiodate [65,66]. For immunostaining, the grids were floated
on top of drops of immune reagents displayed on a sheet of
parafilm. Free aldehyde groups were blocked with 50 mM glycine,
and the grids were then incubated with 5% (vol/vol) goat serum in
incubation buffer [0.2% bovine serum albumin-C in PBS, pH 7.6]
for 15 min. This blocking procedure was followed by overnight
incubation with primary antibodies (dilution 1:50–1:100) at 4uC.
After washing the grids in 200 ml incubation buffer, floating on
drops containing the gold conjugate reagents (diluted 1:10–1:20 in
incubation buffer) was performed for 60 min at RT. The sizes of
the gold particles used were 10 and 5 nm. After further washes in
incubation buffer, the sections were postfixed in 2% glutaralde-
hyde. Finally, sections were washed in distilled water and
poststained with uranyl acetate and lead citrate and examined
under the electron microscope. Specimens were observed in a Jeol
JEM 1230 electron microscope (JEOL, Tokyo, Japan) operated at
60 kV accelerating voltage. Images were recorded with a Gatan
Multiscan 791 CCD camera (Gatan, Pleasanton, CA).
RNA isolation and quantitative real-time reverse
transcription-polymerase chain reaction (RT-PCR)
Stimulated B cells were lysed in RLT buffer (Qiagen, Hilden,
Germany), supplemented with 1% 2-mercaptoethanol, and stored
at 280uC until use. RNA was extracted using an RNeasy Mini Kit
(Qiagen). The quantity and quality of the RNA was determined by
spectrophotometry using the A260/280 ratio. The Omniscript
Reverse Transcriptase kit (Qiagen) and Oligo(dT)15 primer
(Novagen, Nottingham, UK) were used for first-strand cDNA
synthesis with an aliquot of 20 ng RNA as starting material. The
resulting cDNA was diluted with water and 18 ng was used for
amplification. The RT-PCR was performed on a Smart Cycler
(Cepheid, Sunnyvale, CA) using TaqMan Universal PCR Master
Mix, No AmpErase UNG and Assay-on-Demand Gene Expres-
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unlabelled primers and MGB probe (FAM
TM dye-labelled). The
thermal cycler was programmed to perform an initial set-up (95uC,
10 min) and 45 cycles of denaturation (95uC, 15 seconds) followed
by annealing/extension (60uC, 1 min). The relative amounts of
mRNA for TLR9 were determined by subtracting threshold (Ct)
values for these genes from the Ct value for the internal control
gene b-actin (DCt). Data were depicted as 2
DCt610
5 and presented
as mean values6standard error of the mean (SEM).
Statistical analysis
Statistical analysis was performed using GraphPad PRISM 5
(San Diego, CA) and significance was calculated with one-way
repeated measures ANOVA with Dunett’s multiple comparison
test (for comparisons of more than two data sets). The Student’s t-
test was used to determine statistical differences for unpaired
comparisons with Welch correction if variances were non-
homogenous. Significant values were defined as *, p#0.05; **,
p#0.01. All data are expressed as mean6SEM, and n corresponds
to the number of experiments performed.
Accesion numbers
MID/Hag (AAX56613).
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